Laying out the changing landscape of hepatitis C: Potential programming implications in prevention, testing, treatment and care
- Surveillance and epidemiology of hepatitis C in Canada
- Best practice recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: Part 1
- Hepatitis C in migrants: An underappreciated group at increased risk
The landscape of hepatitis C is changing. New, national harm reduction practices may improve hepatitis C prevention; new research shows that sexual transmission of hepatitis C via blood contact may be increasing among gay men and other men who have sex with men; and new, more effective treatments will challenge our clinical capacity to treat hepatitis C.
These pre-recorded webinars take a look at some of these recent changes through the lens of specific populations, including people who use drugs, migrants, and gay men and other men who have sex with men.
Surveillance and epidemiology of hepatitis C in Canada
Presented by Max Trubnikov, MD, MSc, PhD; Epidemiologist, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada
Best practice recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: Part 1
Presented by Carol Strike, PhD Associate Professor at the Dalla Lana School of Public Health, University of Toronto
Hepatitis C in migrants: An underappreciated group at increased risk
Presented by Dr. Chris Greenaway, Associate Professor of Medicine, McGill University; Division of Infectious Diseases, Jewish General Hospital; Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research; Dept. of Epidemiology & Biostatistics, McGill University
Sexual transmission of hepatitis C among men who have sex with men: A brief introduction
Presented by Len Tooley, Coordinator, Community Health Promotion Programming, CATIE
Hep C: New therapies and implications
Presented by Curtis Cooper, MD, FRCP; Associate Professor, University of Ottawa; The Ottawa Hospital, Infections Diseases; Director, Ottawa Hospital and Regional Hepatitis Program
Breaking down the barriers to hepatitis C virus treatment among people who use drugs (PWID): A review of the 1st set of international recommendations
Presented by Lesley Gallagher, Hepatitis C Nurse Clinician for Vancouver Coastal Health and the Saskatchewan Infectious Disease Care Network (SIDCN).